Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services informed exchanges that its subsidiary Optival Health Solutions received a two-day suspension order for the Drug License of a store located at Peddamma Temple Road No. 41, Jubilee Hills, Telangana. The order was issued by the Assistant Director, Drugs Control Administration, Hyderabad, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on June 18, 2025. The company estimates a potential revenue loss of around Rs. 0.61 lakhs from the two-day suspension of this single outlet. The action pertains to only one store and the financial impact is negligible compared to Medplus's overall operations.
The impact is minor and limited to a single store with a two-day suspension causing a revenue loss of just Rs. 0.61 lakhs. This is a routine compliance matter unlikely to materially affect the company's financial performance or stock price.